Xyzal (Levocetirizine Dihydrochloride) - Summary

XYZAL SUMMARY

Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is an orally active H₁- receptor antagonist.

Allergic Rhinitis

XYZAL^® is indicated for the relief of symptoms associated with allergic rhinitis (seasonal and perennial) in adults and children 6 years of age and older.

Chronic Idiopathic Urticaria

XYZAL is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older.

See all Xyzal indications & dosage >>

XYZAL NEWS HIGHLIGHTS

Media Articles Related to Xyzal (Levocetirizine)

Morria Biopharmaceuticals Plc Announces Positive Clinical Results For MRX-4 In Its Phase II Clinical Study In Allergic Rhinitis Patients
Source: Arthritis / Rheumatology News From Medical News Today [2008.11.07]

Children With Hay Fever More Likely To Experience Headaches, Facial Pain
Source: Headache / Migraine News From Medical News Today [2008.09.23]

more >>

Published Studies Related to Xyzal (Levocetirizine)

Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. [2008.09]

Determination of levocetirizine in human plasma by liquid chromatography-electrospray tandem mass spectrometry: application to a bioequivalence study. [2008.02.01]

Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. [2008.02]

Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. [2007.11]

Safety of levocetirizine treatment in young atopic children: An 18-month study. [2007.09]

more >>

Clinical Trials Related to Xyzal (Levocetirizine)

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months [Recruiting]

The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria [Recruiting]

more >>